Which Micron AI chip contract legal risks are verifiable?

For Micron AI-chip contract and stock-risk diligence, the useful starting point is not whether HBM and DRAM demand from AI infrastructure is believable. It is. The narrower question is which legal exposures can be tied to a court, agency instrument, filing date, amount, or named source, and which items are merely stale disclosure language or market shorthand.

The table does two things the stock conversation usually skips. First, it separates binding instruments and docket events from enforcement examples and policy analysis. Second, it marks the most important timing problem: Micron’s Q1 FY2026 Form 10-Q, for the quarter ended Nov. 27, 2025, could still describe the securities case as pending, but the available case record now shows dismissal activity in February and April 2026.[1][2]

The 10-Q snapshot is not the current docket

Micron’s Q1 FY2026 10-Q is still the right anchor for company-stated litigation and revenue concentration facts. It discloses the Netlist verdict and appeal posture, the PTAB unpatentability decisions and Netlist’s Federal Circuit appeals, the YMTC multi-forum litigation map, and customer concentration information. It also states that approximately one-third of FY2025 revenue came from non-U.S.-headquartered customers, approximately 80% of revenue shipped to non-U.S. locations, and more than half of revenue came from Micron’s top ten customers.[1]

Those are company disclosures, and they deserve more weight than unsourced summaries. But they are not a live docket feed. The securities class action is the clean example: the current supplied case record identifies District of Idaho Case No. 25-cv-00191 before Judge B. Lynn Winmill, a class period of Mar. 29, 2023 through Dec. 18, 2024, a motion-to-dismiss grant on Feb. 3, 2026, and a voluntary dismissal on Apr. 3, 2026.[2] That does not erase every shareholder-litigation diligence question. It does mean that a memo treating that class action as simply “pending,” without a 2026 docket check, is carrying forward an outdated risk state.

Export controls and tariffs now carry live operational weight

The export-control bucket should not be reduced to “China risk.” There are at least three different kinds of material in the record: binding licensing rules, tariff exposure, and enforcement examples from the wider AI-chip ecosystem. They do different work in a risk file.

The binding export-control item is the BIS final rule published and effective Jan. 15, 2026. The rule moved H200/MI325X-class chips to case-by-case licensing and attached certifications that include know-your-customer obligations, third-party U.S. testing labs, remote-end-user disclosure, no-foundry-diversion certification, and a 50%-of-U.S.-shipments China TPP cap.[3] That is not a Micron enforcement action. It is a compliance architecture that can matter to any advanced-computing supply chain whose product, destination, end user, or transaction structure enters the covered zone.

The tariff item is separate. Mayer Brown’s Jan. 16, 2026 analysis describes a Jan. 14, 2026 Section 232 proclamation imposing a 25% tariff on covered advanced AI chips.[4] For contract review, that belongs in a different line from BIS licensing. A licensing condition may stop, delay, or condition shipment. A tariff may reallocate cost, trigger price-adjustment language, or create customs-classification disputes. The same AI-chip commercial relationship can implicate both, but the legal instruments are not interchangeable.

The enforcement examples make the compliance bucket concrete without turning into Micron-specific allegations. Morrison Foerster’s February 2026 survey describes Operation Gatekeeper at approximately $160 million on Dec. 8, 2025, Cadence’s July 2025 resolution involving a $95 million penalty plus $45 million in forfeitures, and additional examples involving Janford Realtor, ALX Solutions, and Exyte, including a $1.5 million Exyte settlement.[5] Those examples are useful because they show the kinds of conduct and controls regulators are testing across the ecosystem. They should not be cited as evidence that Micron has violated those rules.

For diligence teams, the practical review is product- and transaction-specific. A Micron AI-memory supply contract should be checked for export classification, customer and end-user representations, destination and remote-access controls, audit and certification mechanics, diversion remedies, tariff allocation, change-in-law clauses, and termination rights if a license is denied or conditioned. The site’s U.S.-China AI chip export-controls tracker is the more complete place to map the licensing framework; this register’s job is to show why that framework has become a live legal-risk bucket for Micron-facing AI-memory diligence.

HBM deserves its own caution. The AI Frontiers / IAPS analysis is not a rule, but it is relevant because it identifies high-bandwidth memory as a place where export-control coverage may lag the role HBM plays in AI accelerator performance.[8] That kind of policy analysis should not be converted into a current legal prohibition. It should be converted into questions: whether the memory product is separately controlled, whether it is bundled with controlled accelerators, whether technical assistance or testing creates additional exposure, and whether a contract’s compliance clauses survive a later rule change.

Patent litigation: keep the verdicts, PTAB decisions, and appeals in the same frame

Patent risk is the other bucket that still requires real space in a Micron AI-memory file. The mistake to avoid is compressing multi-forum patent records into “Micron lost” or “the patents were invalidated.” The supplied record supports neither simplification.

Netlist

Micron’s 10-Q discloses a May 23, 2024 Eastern District of Texas jury award in Netlist litigation: $425 million on the ’912 patent and $20 million on the ’417 patent, with a willfulness finding. The same disclosure says Micron appealed on July 9, 2025.[1]

The same 10-Q also discloses PTAB final written decisions holding both patents unpatentable, with Netlist’s Federal Circuit appeals pending.[1] That is the live register entry. The district-court verdict and willfulness finding matter. So do the PTAB decisions. So do the appeals. A contract-risk memo that uses only one side of that record is not just incomplete; it may misstate the posture a counterparty or insurer will care about.

The consequence for Micron-facing AI-memory contracts is not that a single damages figure automatically predicts final liability. The consequence is that indemnity language, patent-risk allocation, escrow or reserve assumptions, and disclosure schedules should refer to the actual proceedings and appeal posture. A willfulness finding has a different risk profile from a routine infringement dispute, but PTAB unpatentability decisions under Federal Circuit review also change how counsel should describe finality.

YMTC

YMTC belongs in the patent bucket because the supplied Micron filing gives a forum map, not because “China” is a sufficient legal category. Micron’s 10-Q discloses YMTC patent actions across the Northern District of California, Eastern District of Texas, Beijing and Shanghai IP courts, the London High Court, the Unified Patent Court in Düsseldorf, and Munich Regional Court. It also discloses YMTC’s June 7, 2025 Lanham Act false-advertising suit in the District of Columbia.[1]

That spread matters for procedure. The same commercial dispute can move through U.S. patent litigation, Chinese IP courts, European patent venues, and a U.S. false-advertising claim on different clocks. A single global settlement, a venue-specific injunction, a validity ruling in one jurisdiction, or a claim-construction ruling in another may change the risk profile unevenly. The register therefore should not treat the YMTC matters as one undifferentiated overhang unless the memo also names the forum being discussed.

Securities and derivative actions: the reweighting item

The securities class action is important here mostly because it changed status after the 10-Q snapshot. The supplied record identifies the case as District of Idaho Case No. 25-cv-00191 before Judge B. Lynn Winmill, with an alleged class period from Mar. 29, 2023 through Dec. 18, 2024. It then records that the motion to dismiss was granted on Feb. 3, 2026 and that a voluntary dismissal followed on Apr. 3, 2026.[2]

That is a material status change. It moves the securities class action out of the live-exposure column for purposes of this Q3 2026 register, subject to any docket nuance not reflected in the supplied case page. It does not automatically dispose of derivative suits or related proceedings. Any derivative action that was stayed, derivative in posture, or separately captioned has to be checked on its own docket. The class action’s dismissal is not a universal litigation solvent.

This is where many risk notes go stale. A Form 10-Q is authoritative for what the company disclosed when filed. It is not the last word once a court grants a motion to dismiss months later. For a legal journalist or KM team updating a Micron file, the entry should read as a post-filing dismissal, not as a live securities cloud carried forward from the filing language.

CAC ban and China-facing revenue: confirmed action, narrower inference

The China regulatory item is confirmed but narrower than many summaries make it. Stanford DigiChina records that China’s Cyberspace Administration announced its Micron cybersecurity review on Mar. 31, 2023 and that the resulting ban became effective on May 21, 2023, restricting operators of critical information infrastructure from purchasing Micron products.[6] That is the agency-action entry.

CSIS’s June 22, 2023 analysis characterized the ban as a tactical move by Beijing.[7] That is a policy interpretation, not an evidentiary finding by a court. It can help explain why the ban belongs in a broader U.S.-China chip-control file, alongside pieces such as the site’s discussion of the China chip-export-controls fault line. It should not be cited as proof that every later Micron revenue movement in China was caused by the CAC action.

The clean company-stated revenue facts in the supplied record are more general: Micron disclosed that in FY2025 approximately one-third of revenue came from customers headquartered outside the United States, approximately 80% of revenue was shipped to non-U.S. locations, and more than half of revenue came from its top ten customers.[1] Those numbers support geographic and customer-concentration diligence. They do not, by themselves, quantify the CAC ban’s effect.

Secondary market commentary and media reporting may give more China-specific revenue estimates or describe product-line exits. Those figures should be labeled as analyst- or media-reported unless the underlying Micron filing says the same thing. In this register, the CAC ban is confirmed; the business-impact explanation remains source-dependent.

Where the live weight sits as of Q3 2026

As of Aug. 4, 2026 UTC, the live Micron AI-memory legal-risk register is not best measured by the stale securities-litigation line in the Q1 FY2026 10-Q or by a stock-market phrase such as “legal overhang.” The securities class action has a post-filing dismissal record. The CAC ban is real, but its revenue consequences require careful attribution. The heavier live work sits in export-control and tariff compliance on one side, and multi-forum patent litigation on the other.

That produces a simple drafting rule for counsel and reporters: name the instrument, forum, date, and status. If the item is a BIS rule, say so. If it is a Section 232 tariff, keep it separate. If it is a Netlist verdict, state the award and appeal posture together with the PTAB and Federal Circuit status. If it is YMTC, identify the venue. If it is the dismissed securities case, do not let an older filing turn it back into a pending one.

References

1. Form 10-Q for the quarterly period ended November 27, 2025 — SEC
2. Micron Technology, Inc. — Kessler Topaz Meltzer & Check
3. Revision to License Review Policy for Advanced Computing Commodities — Federal Register, January 15, 2026
4. Administration Policies on Advanced AI Chips Codified — Mayer Brown, January 16, 2026
5. Managing Export Control Risks in the AI Chip Ecosystem — Morrison Foerster, February 2026
6. Targeting U.S. Chip Firm Micron, China’s Cybersecurity Reviews Continue to Evolve — Stanford DigiChina
7. Micron Aggression? The Right Response to Beijing’s Ban on a U.S. Chipmaker — CSIS, June 22, 2023
8. High-Bandwidth Memory: Critical Gaps in U.S. Export Controls — AI Frontiers / IAPS